RT Journal Article
T1 SEOM clinical guidelines for the treatment of head and neck cancer (2017).
A1 Iglesias Docampo, L C
A1 Arrazubi Arrula, V
A1 Baste Rotllan, N
A1 Carral Maseda, A
A1 Cirauqui Cirauqui, B
A1 Escobar, Y
A1 Lambea Sorrosal, J J
A1 Pastor Borgoñón, M
A1 Rueda, A
A1 Cruz Hernández, J J
K1 Guidelines
K1 HPV
K1 Head and neck cancer
K1 Induction chemotherapy
AB Head and neck cancer (HNC) is defined as malignant tumours located in the upper aerodigestive tract and represents 5% of oncologic cases in adults in Spain. More than 90% of these tumours have squamous histology. In an effort to incorporate evidence obtained since 2013 publication, Spanish Society of Medical Oncology (SEOM) presents an update of HNC diagnosis and treatment guideline. The eighth edition of TNM classification, published in January 2017, introduces important changes for p16-positive oropharyngeal tumours, for lip and oral cavity cancer and for N3 category. In addition, there are new data about induction chemotherapy and the role of immunotherapy in HNC.
YR 2017
FD 2017-11-20
LK http://hdl.handle.net/10668/11825
UL http://hdl.handle.net/10668/11825
LA en
DS RISalud
RD Apr 9, 2025